Time course of peritoneal function in automated and continuous peritoneal dialysis

Peritoneal Dialysis International

Volumn 32, Issue 6, 2012, Pages 605-611

  Michels, Wieneke M ^a,b   Verduijn, Marion ^b   Parikova, Alena ^c   Boeschoten, Elisabeth W ^d   Struijk, Dirk G ^a,e   Dekker, Friedo W ^b   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d Hans Mak Institute   (Netherlands)

^e Dianet Foundation   (Netherlands)

Author keywords

Automated peritoneal dialysis; Continuous ambulatory peritoneal dialysis; Effective lymphatic absorption rate; Peritoneal transport; Standard peritoneal permeability analysis; Ultrafiltration

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; AUTOMATED PERITONEAL DIALYSIS; AUTOMATION; CAPILLARY PERMEABILITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; EARLY INTERVENTION; FEMALE; FLUID TRANSPORT; HUMAN; INTERMETHOD COMPARISON; LYMPH FLOW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SOLUTE; TREATMENT DURATION; ULTRAFILTRATION; WATER TRANSPORT;

ADULT; AGED; DIALYSIS SOLUTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; ULTRAFILTRATION;

EID: 84870990086     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00166     Document Type: Article

References (37)

1. Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int 1999; 19:526-33.
2. Gallar P, Ortega O, Carreno A, Vigil A. Rate of decline in residual renal function is equal in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2000; 20:803-5.
3. Hidaka H, Nakao T. Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis. Nephrology (Carlton) 2003; 8:184-91.
4. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A. Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit Dial Int 1996; 16:307-15.
5. Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients. Perit Dial Int 2001; 21:302-5.
6. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 1999; 14:1224-8.
7. Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, et al. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int 2003; 23:276-83.
8. Liao CT, Shiao CC, Huang JW, Hung KY, Chuang HF, Chen YM, et al. Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients. Perit Dial Int 2008; 28(Suppl 3):S191-5.
9. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11:556-64.
10. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000; 20:429-38.
11. Ortega O, Gallar P, Carreño A, Gutierrez M, Rodriguez I, Oliet A, et al. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control. Am J Nephrol 2001; 21:189-93.
12. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
13. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9:41-5.
14. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
15. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59:348-57.
16. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
17. Selgas R, Fernandez-Reyes MJ, Bosque E, Bajo MA, Borrego F, Jimenez C, et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23:64-73.
18. Breborowicz A, Martis L, Oreopoulos DG. Changes in biocompatibility of dialysis fluid during its dwell in the peritoneal cavity. Perit Dial Int 1995; 15:152-7.
19. Fusshöller A, zur Nieden S, Grabensee B, Plum J. Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 2002; 13:1055-60.
20. La Milia V, Limardo M, Cavalli A, Crepaldi M, Locatelli F. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis. Nephrol Dial Transplant 2009; 24:2894-8.
21. Rodriguez-Carmona A, Pérez-Fontán M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-45.
22. Smit W, van Dijk P, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23:440-9.
23. Pannekeet MM, Imholz AL, Struijk DG, Koomen GC, Langedijk MJ, Schouten N, et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48:866-75.
24. Renck H, Ljungström KG, Hedin H, Richter W. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20mL dextran 1, 15%, administered before dextran70 or dextran 40. Acta Chir Scand 1983; 149:355-60.
25. Koomen GC, Krediet RT, Leegwater AC, Struijk DG, Arisz L, Hoek FJ. A fast reliable method for the measurement of intraperitoneal dextran70, used to calculate lymphatic absorption. Adv Perit Dial 1991; 7:10-14.
26. Smit W, Struijk DG, Ho-Dac-Pannekeet MM, Krediet RT. Quantification of free water transport in peritoneal dialysis. Kidney Int 2004; 66:849-54.
27. Westra WM, Smit W, Zweers MM, Struijk DG, Krediet RT. Diffusion correction of sodium sieving applicable in a peritoneal equilibration test. Adv Perit Dial 2003; 19:6-9.
28. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997; 51:888-93.
29. Akman S, van Westrhenen R, De Waart DR, Hiralall JK, Zweers MM, Krediet RT. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2003; 19:24-7.
30. Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43:1339-46.
31. Krediet RT, Zemel D, Struijk DG, Koomen GC, Arisz L. Individual characterization of the peritoneal restriction barrier to macromolecules. Adv Perit Dial 1991; 7:15-20.
32. Zemel D, Krediet RT, Koomen GC, Struijk DG, Arisz L. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991; 11:217-23.
33. Badve SV, Hawley CM, McDonald SP, Mudge DW, Rosman JB, Brown FG, et al. Automated and continuous ambulatory peritoneal dialysis have similar outcomes. Kidney Int 2008; 73:480-8.
34. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 2009; 76:97-107.
35. Michels WM, Verduijn M, Boeschoten EW, Dekker FW, Krediet RT. Similar survival on automated peritoneal dialysis and continuous ambulatory peritoneal dialysis in a large prospective cohort. Clin J Am Soc Nephrol 2009; 4:943-9.
36. Imholz AL, Koomen GC, Voorn WJ, Struijk DG, Arisz L, Krediet RT. Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. Nephrol Dial Transplant 1998; 13:146-53.
37. Michels WM, Zweers MM, Smit W, Korevaar J, Struijk DG, van Westrhenen R, et al. Does lymphatic absorption change with the duration of peritoneal dialysis? Perit Dial Int 2004; 24:347-52.